Financial Comparison
Abbott Laboratories vs Baxter International Inc.
Click a ticker to view the full analysis.
ABT vs
In short
Abbott Laboratories is the more profitable of the two, keeping 14.7% of revenue as net profit against -8.5% for Baxter International Inc. Fisclear flags 1 medium- or high-severity risk for Abbott Laboratories and 2 for Baxter International Inc.
Based on filings for periods ending 30 Jun 2026 (ABT) and 30 Jun 2026 (BAX) · Updated
FisclearScore Comparison
ABT63Fair
BAX46Weak
Quality+1
53
54
Efficiency+40
70
30
Value+26
62
36
Cashflow+17
79
62
Regime
55
55
Peers+14
56
42
FisclearScore is a quantitative model. ABT shown solid · BAX shown dashed. Not financial advice.
| Metric | ABT | BAX |
|---|---|---|
| Price | $98.49 | $23.90 |
| Market Cap | $171.6B | $12.4B |
| P/E (TTM) | 31.9x | — |
| P/B | 3.3x | 2.0x |
| Beta | 0.58 | 0.65 |
| Div Yield | 2.48% | 0.16% |
| Revenue (TTM) | $44.3B | $11.2B |
| Net Income | $6.5B | -$957M |
| Gross Margin | — | 30.1% |
| Risk Flags | 1 flag | 2 flags |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.